Yoshio Takayanagi
- Co-authors
- Ken‐ichi SasakiHiroaki KawauchiKazuo NittaMasahiro HosonoMasaaki IshikawaReiko MinekiKimie MurayamaShinobu Furusawa
- Topics
- Glycosylation and Glycoproteins Research (10 papers)Chemotherapy-induced organ toxicity mitigation (10 papers)Pharmacogenetics and Drug Metabolism (7 papers)
- Cited by
- ImmunologyPharmacologyBiochemistry
- Journals
- Biochemical and Biophysical Research CommunicationsCellular and Molecular Life SciencesBiochimica et Biophysica Acta (BBA) - General Subjects
- Partner nations
- JapanIndiaUnited States
In The Last Decade
Yoshio Takayanagi
59 papers receiving 753 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 417
- Immunology 265
- Pathology and Forensic Medicine 83
- Pharmacology 75
- Oncology 74
Countries citing papers authored by Yoshio Takayanagi
This map shows the geographic impact of Yoshio Takayanagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Takayanagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Takayanagi more than expected).
Fields of papers citing papers by Yoshio Takayanagi
This network shows the impact of papers produced by Yoshio Takayanagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Takayanagi. The network helps show where Yoshio Takayanagi may publish in the future.
Co-authorship network of co-authors of Yoshio Takayanagi
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Takayanagi. A scholar is included among the top collaborators of Yoshio Takayanagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Takayanagi. Yoshio Takayanagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 6 | |
| 3 | 7 | |
| 4 | 6 | |
| 5 | 88 | |
| 6 | 5 | |
| 7 | 28 | |
| 8 | Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells. | 10 |
| 9 | 1 | |
| 10 | 30 | |
| 11 | 4 | |
| 12 | 30 | |
| 13 | 3 | |
| 14 | 24 | |
| 15 | 4 | |
| 16 | 3 | |
| 17 | 2 | |
| 18 | 37 | |
| 19 | 14 | |
| 20 | 12 |
About Yoshio Takayanagi
Yoshio Takayanagi is a scholar working on Biochemistry, Pharmacology and Immunology, having authored 61 papers that have together received 769 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (10 papers), Chemotherapy-induced organ toxicity mitigation (10 papers) and Pharmacogenetics and Drug Metabolism (7 papers). The work is most often cited by research in Immunology (265 citations), Pharmacology (75 citations) and Biochemistry (47 citations). Yoshio Takayanagi has collaborated with scholars based in Japan, India and United States. Frequent co-authors include Ken‐ichi Sasaki, Hiroaki Kawauchi, Kazuo Nitta, Masahiro Hosono, Masaaki Ishikawa, Reiko Mineki, Kimie Murayama, Shinobu Furusawa, Shuhei Sakaguchi and Motoaki Takayanagi. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cellular and Molecular Life Sciences and Biochimica et Biophysica Acta (BBA) - General Subjects.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.